✦ LIBER ✦

Effect of lymphoblastoid alfa-interferon in patients with chronic hepatitis C having different genotypic subtype of hepatitis C virus

✍ Scribed by Chayama, Kazuaki ;Tsubota, Akihito ;Arase, Yasuji ;Saitoh, Satoshi ;Ikeda, Kenji ;Matsumoto, Toyomi ;Sakai, Yoko ;Kobayashi, Mariko ;Morinaga, Tsuto ;Kumada, Hiromitsu

Publisher: Springer-Verlag
Year: 1993
Tongue: English
Weight: 193 KB
Volume: 28
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02989204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of hepatitis C virus core p

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

✍ E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa

Effect of interferon administration on s

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C

✍ Kazuaki Chayama; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Toyomi Matsumoto; Yo 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m

A pilot study of corticosteroid priming

A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C

✍ K Chayama; A Tsubota; M Kobayashi; M Hashimoto; Y Miyano; H Koike; M Kobayashi; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

These factors are important, because they may influpolymerase chain reaction. ence the outcome of treatment. Furthermore, the study From the Department of Gastroenterology, Toranomon Hospital, Okinaka did not evaluate the effect of treatment on HCV clear-Memorial Institute for Medical Research, Tor

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Effects of genotypes of hepatitis C viru

Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis

✍ Takada, Nobuo ;Takase, Shujiro ;Takada, Akira 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 659 KB

Hepatitis B virus subtypes and hepatitis

Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal

✍ Santosh Man Shrestha; Fumio Tsuda; Hiroaki Okamoto; Hajime Tokita; Minoru Horiki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

A total of 146 patients with chronic liver disease, including 20 with chronic hepatitis, 63 with cirrhosis and 62 with primary hepatocellular carcinoma from Nepal were tested for markers of hepatitis B virus or hepatitis C virus infection. HBsAg was detected in 57 (39%) and hepatitis C virus RNA in